We evaluated ctDNA status and dynamics during surveillance and as part of TRM with clinical outcomes in both patients with clear cell renal cell carcinoma (ccRCC) and non–clear cell renal cell ...
SAN FRANCISCO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- TRM Labs, the leader in blockchain intelligence, today announced that it is the first blockchain intelligence company to achieve FedRAMP High ...
SAN FRANCISCO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- TRM Labs, the leader in blockchain intelligence, today announced achieving FedRAMP High authorization and is now listed on the FedRAMP Marketplace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback